Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cohance Lifesciences is a leading Indian CDMO and API platform offering end-to-end services from development to commercialization. The company supports global pharmaceutical innovators with process R&D, manufacturing of APIs/intermediates/formulations, clinical research services including bioavailability/bioequivalence studies, and has expanded technical capabilities via recent acquisitions in oligonucleotides and antibody-drug conjugates. It operates over 100 active projects across all phases of drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cohance Lifesciences.